UW Medicine Banner UW Medicine Home Page UW Department of Obstetrics and Gynecology Home Page
Support our Mission:
Make a
Tax-Deductible
Donation
Take me to:
Mission Statement  
Clinical Services
Faculty
Divisions
Research
Professional Education
Calendar & News
Links & Resources
Ob/Gyn Dept Home  
Ob/Gyn Clerkship
Divisions of Gynecologic Oncology & Education
Ron Swensen, MD

Ron E Swensen, MD
Associate Professor
Director, 4th Year Clerkship, Gynecologic Oncology

University of Washington
Department of Obstetrics & Gynecology
Box 356460
Seattle, WA 98195-6460

Main | Affiliations | Publications

Academic Office:
Clinic Appts:
(206) 543-3669
(206) 288-2273 (new patients)
(206) 288-6200 (returning patients)
Specialties:
Gynecologic Oncology:
• Clinical trials for gynecologic malignancies
• Complex gynecologic oncology services
• Application of biological modifiers to treatment of gynecologic malignancies
Licensure:
• Washington, 2003
Certification:
• Obstetrics and Gynecology, 1990 (recertified 1998)
• Gynecologic Oncology, 1998
Joined UW Medicine: 7/1/03
Education:

• MD degree
   (Loma Linda University, 1984)
• Residency in Obstetrics and Gynecology
   (Stanford University Hospital, 1988)
• Fellowship in Gynecologic Oncology
   (Hershey Medical Center, 1995)

Current
Research:
A Phase II Trial of Granulocyte-Macrophage Colony-Stimulating Factor
  (GM-CSF) with Weekly PROTEIN Bound Paclitaxel (Abraxane™) as
  Chemoimmunotherapy for Relapsed, Platinum-Resistant Epithelial
  Ovarian Cancer
Professional 
Organizations:

• American College of Obstetricians and Gynecologists
• American Society of Clinical Oncology
• Cooperative Oncology Group for Immunotherapy
• Gynecologic Oncology Group
• International Gynecologic Cancer Society
• Society of Gynecologic Oncologists
• Washington State Medical Society
• Western Association of Gynecologic Oncologists
• Alpha Omega Alpha Medical Honor Society

Selected 
Publications:

Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol. 2008;109(1):53-8.

Salazar LG, Coveler AL, Swensen RE, Gooley TA, Goodell V, Schiffman K, Disis ML. Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers. Clin Immunol. 2007 Dec;125(3):275-80.

Swisher EJ, Swensen RE, Greer B, Tamimi H, Goff BA, Garcia R, Koh WJ. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol. 2006;101:426-35.

Goodell V, Salazar L, Urban N, Drescher CW, Gray HJ, Swensen RE, McIntosh MW, Disis ML. Antibody immunity to oncogenic proteins is a prognostic indicator in ovarian cancer. J Clinic Oncol. 2006;24(5):762-8.

Greer BE, Swensen RE, Gray HJ. Surgery for ovarian cancer: rationale and guidelines. JNCCN. 2004;2(6):561-568.

Bojalian MO, Machado GR, Swensen R, Reeves ME. Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. Gynecol Oncol 2004;93:557–60.

Swensen RE, Garcia RL, Goff BA. Ovarian metastasis from gastrointestinal tract cancer: a review. CME J Gynecol Oncol 2004;8:352–61.

Caffrey AS, Patton WC, Corselli JU, Swensen RE, King A, Chan PJ. Cyclooxygenase (COX-2) and granulosa cell apoptosis in-vitro. J Assist Reprod Genet 2002;19(12):577–81.



Home | Mission Statement | Clinical Services | Patient Education | Faculty | Divisions | Research | Professional Education | Calendar & News | Links
Copyright © 2009 University of Washington
Please report problems to Webmaster.UW.ObGyn [at] (Webmaster)
spacer